Leroux-Roels I, Maes C, Mancini F, Jacobs B, et al. Safety and immunogenicity of a 4-component GMMA-based Shigella vaccine in healthy European adults: Stage 1 of a randomized, controlled phase I/II clinical trial. J Infect Dis 2024 Jun 10:jiae273. doi: 10.1093.
PMID: 38853614